Massachusetts Financial Services’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARCT
AIM
NAMA
Massachusetts Financial Services's ARCT Position: Q2 2026 in Review
Massachusetts Financial Services reduced its Arcturus Therapeutics (ARCT) stake by 3.8% in Q2 2026, selling an estimated $18.1K and leaving 57,480 shares worth $386K. The position accounts for ﹤0.01% of the portfolio, ranked #965.
Massachusetts Financial Services first reported a position in ARCT in Q3 2020 and has held it in 16 quarters since. The position peaked at $1.39M in Q1 2024. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.
- Massachusetts Financial Services held 57,480 shares of Arcturus Therapeutics worth $386K as of Q2 2026.
- Massachusetts Financial Services sold 2,290 Arcturus Therapeutics shares in Q2 2026, an estimated $18.1K.
- Arcturus Therapeutics made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #965 holding.
- Massachusetts Financial Services first reported a position in Arcturus Therapeutics in Q3 2020 and has held it in 16 quarters since.
- Massachusetts Financial Services's Arcturus Therapeutics position peaked at $1.39M in Q1 2024.
- 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.
Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.